These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 5700152)

  • 1. Effects of intravenous infusion of autogenous ascitic fluid and tolbutamide therapy on protein and electrolyte metabolism in decompensated cirrhosis of the liver.
    Misra SS; Teotia SP; Tandon RK
    J Assoc Physicians India; 1968 Aug; 16(8):475-88. PubMed ID: 5700152
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autogenous intravenous infusion of ascitic fluid in patients with liver cirrhosis].
    Selmi W
    Minerva Med; 1973; 64(53):2764-74. PubMed ID: 4726749
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience in the treatment of diuretic-resistant ascites in liver cirrhosis by intravenous infusion of autogenous ascitic fluid].
    Matsuoka K; Ueda Y; Kimura M; Mashiba Y; Kitsuki K
    Naika; 1971; 28(1):163-7. PubMed ID: 5565686
    [No Abstract]   [Full Text] [Related]  

  • 4. Trial of tolbutamide in the treatment of decompensated cirrhosis of liver.
    Paul D; Nath K; Kumar D
    J Assoc Physicians India; 1965 Nov; 13(11):875-82. PubMed ID: 5852371
    [No Abstract]   [Full Text] [Related]  

  • 5. [Infusion of autogenous ascitic fluid in the therapy of liver cirrhosis].
    Lo Presti A; Pugliese F; Palmas F
    Minerva Gastroenterol; 1969; 15(1):6-19. PubMed ID: 5385840
    [No Abstract]   [Full Text] [Related]  

  • 6. Refractory ascites in chronic dialysis patients.
    Gutch CF; Mahony JF; Pingerra W; Holmes JH; Ramirez G; Ogden DA
    Clin Nephrol; 1974; 2(2):59-62. PubMed ID: 4830513
    [No Abstract]   [Full Text] [Related]  

  • 7. [Puncture-concentration-reinjection of ascitic fluid in patients with cirrhosis. Appreciation of results].
    Paris J; Paris JC; Lefebvre J; Herbeau G; Voiment YM; Roger J; Filoche B
    Lille Med; 1973; 18(7):769-77. PubMed ID: 4794627
    [No Abstract]   [Full Text] [Related]  

  • 8. Concentrations of gentamicin in ascitic fluid after intravenous infusion.
    Fevery J; Zachee P; Verbist L
    Neth J Med; 1983; 26(7):191-2. PubMed ID: 6633753
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies on the effects of aldosterone and anti-aldosterone compounds on water and electrolyte metabolism. I. Clinical studies on the effects of aldosterone and anti-aldosterone compounds which act on renal tubule of water and electrolyte metabolism].
    Matsuda T
    Naika Hokan; 1967 Jan; 14(1):19-33. PubMed ID: 5624510
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dynamics of ascitic fluid in decompensated cirrhosis].
    Milani A; Mazzone M; Rossi L
    Recenti Prog Med; 1999 Feb; 90(2):94-9. PubMed ID: 10208100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavior of glomerular filtrate and water sodium and potassium diuresis in ascitic liver cirrhosis during prolonged administration of cortisone drugs].
    Colucci CF; Castaldo A; De Luca FP
    Policlinico Prat; 1968 Aug; 75(34):1101-8. PubMed ID: 5736920
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum and ascitic fluid gamma glutamyl transpeptidase in cirrhosis of liver.
    Seth ON; Agarwal BD; Kumar S; Srivastava DK; Gupta OK; Khan HS
    J Assoc Physicians India; 1982 May; 30(5):299-303. PubMed ID: 6132910
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of chronic hepatitis and liver cirrhosis with the oral antidiabetic tolbutamide (Orabet)].
    Schimmelpfennig W; Wagner K; Schneider G; Theuer D; Schimmelpfennig R; Zimmermann HB; Hecht A
    Dtsch Gesundheitsw; 1969 Oct; 24(44):2074-9. PubMed ID: 5385540
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glucose and insulin in the blood and ascitic fluid after oral administration of glucose in hepatic cirrhosis].
    Greco AV; Rebuzzi AG; Altomonte L; Manna R; Ghirlanda G
    Minerva Dietol Gastroenterol; 1982; 28(2):133-6. PubMed ID: 7048132
    [No Abstract]   [Full Text] [Related]  

  • 15. [Water-salt metabolism in patients with liver cirrhosis].
    Pakhmurnyĭ BA; Usov DV; Flat KL
    Ter Arkh; 1968 Jul; 40(7):21-4. PubMed ID: 5739328
    [No Abstract]   [Full Text] [Related]  

  • 16. [Application of the water loading test in estimating the degree of liver efficiency in diseases connected with hepatic impairment].
    Jasieński S; Gurak A
    Przegl Lek; 1968; 24(8):645-9. PubMed ID: 5758003
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinolytic characteristics and their significance in malignant, tuberculous and cirrhotic pleural and ascitic fluids.
    Lu XG; Mao JS; Tong JF; Zhu L; Liu J; Gong XB; Huang J
    Int J Lab Hematol; 2007 Apr; 29(2):132-8. PubMed ID: 17474886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disorders of water-electrolyte balance in chronic hepatitis and liver cirrhosis].
    Dederer IuM; Rozhkova TA
    Ter Arkh; 1975; 47(2):72-8. PubMed ID: 1145463
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical studies on the effects of aldosterone and anti-aldosterone compounds on water and electrolyte metabolism. II. Clinical studies on the effects of compounds which inhibit aldosterone synthesis on water and electrolyte metabolism].
    Matsuda T
    Naika Hokan; 1967 Jan; 14(1):35-41. PubMed ID: 4169463
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic value of laboratory examination of ascites fluid (author's transl)].
    Wördehoff D
    Leber Magen Darm; 1981 Jan; 11(1):25-30. PubMed ID: 6163937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.